February 19, 2026
National Institute of Allergy and Infectious Diseases (NIAID)
The purpose of this Notice is to inform the extramural community that PAR-25-300, Targeting Cell Surface HIV Envelope for Cell Elimination (R01 Clinical Trial Not Allowed) will be expired effective immediately. No further applications will be accepted for this notice of funding opportunity (NOFO).
Please direct all inquiries to:
National Institute of Allergy and Infectious Diseases